Evidence map›Paper›PMID 24012789›Full record

ArticleProtein expression and purification2013

Identifying post-translational modifications of NEMO by tandem mass spectrometry after high affinity purification.

Shawn S Jackson, Emma E Coughlin, Joshua J Coon, Shigeki Miyamoto

Open access · greenAbstract read
In one paragraph

Article in Protein expression and purification, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Shawn S JacksonMcArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison, 6159 Wisconsin Institute for Medical Research, 1111 Highland Avenue, Madison, WI 53705, USA; Medical Scientist Training Program, University of Wisconsin-Madison, 6159 Wisconsin Institute for Medical Research, 1111 Highland Avenue, Madison, WI 53705, USA; Cellular and Molecular Biology Program, University of Wisconsin-Madison, 6159 Wisconsin Institute for Medical Research, 1111 Highland Avenue, Madison, WI 53705, USA.
Emma E Coughlin
Joshua J Coon
Shigeki Miyamoto
Wisconsin Institutes for Discovery · USEnergy Center of Wisconsin · USUniversity of Wisconsin–Madison · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
INTEGRATED TRAINING FOR PHYSICIAN-SCIENTISTST32GM008692 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BURKARD, MARK E · 1998 to 2020
$10.3M
Regulation of NEMO modifications in radiation-induced NF-kB signalingR01CA077474 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI MIYAMOTO, SHIGEKI · 2000 to 2014
$4.0M
Sequential Ion/Ion Reactions for Large Peptide and Whole Protein CharacterizationR01GM080148 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI COON, JOSHUA J · 2007 to 2015
$3.0M
Regulation of NF-kappaB by Small Ubiquitin-Like ModifiersR01GM083681 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI MIYAMOTO, SHIGEKI · 2010 to 2013
$1.1M
Defining NEMO interactions to selectively inhibit NF-kB activation by DNA damageF30CA168097 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI JACKSON, SHAWN SIAVASH · 2013 to 2014
$74k
NCI NIH HHS F30 CA168097NCI NIH HHS F30CA171840NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA077474NCI NIH HHS R01CA077474NIGMS NIH HHS R01 GM080148NIGMS NIH HHS R01 GM083681NIGMS NIH HHS R01GM083681NIGMS NIH HHS T32 GM008692
6 · The paper itself

Abstract

An integral component of NF-κB signalling is NEMO, NF-κB essential modulator, a regulatory protein of the IκB kinase (IKK) complex. Post-translational modifications of NEMO, including phosphorylation, SUMOylation, and ubiquitination are critical events during stimuli induced NF-κB activation. Here we demonstrate a method to detect post-translational modifications of NEMO using cells stably expressing polyhistidine tagged NEMO which allows for high-affinity purification of NEMO following rapid denaturing lysis and characterization by MS/MS. We identified a previously uncharacterized basal phosphorylation of NEMO at Serine 387 and tested the biological significance of this phosphorylation through a somatic genetic complementation analysis using the NEMO mutants S387A, S388D, and P388I in 1.3E2 NEMO-deficient murine pre-B cells. NF-κB signalling induced by bacterial lipopolysaccharide, Interleukin-1ß or the DNA damaging agent etoposide was not perturbed by these mutations of NEMO. Thus, S387 phosphorylation of NEMO is not a general requirement to mediate efficient NF-κB signalling and therefore may have cell type and/or stimulus-specific activity in vivo.

Indexed as

Protein Processing, Post-TranslationalAmino Acid SequenceAnimalsCell LineHEK293 CellsHumansI-kappa B KinaseLipopolysaccharidesMiceMolecular Sequence DataMutationNF-kappa BPhosphorylationTandem Mass SpectrometryI-kappa B KinaseIKBKG protein, humanLipopolysaccharidesNF-kappa BMS/MSNEMONF-κBPhosphorylationPolyhistidine purification

Identifiers

PMID24012789
PMCPMC3893115
OpenAlexW2041003294

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.